CD44 and glioblastoma: We observed a significant down-expression of Nestin, Nanog1 and Prom1. Moreover, the down-expression of Cd44, especially on U87MG cell line confirmed the ability of ALDH1A3 inhibitor to interfere with mesenchymal CSCs in glioblastoma.